Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Construction In Progress: ¥1,253 Mil (As of Mar. 2026)

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Construction In Progress?

Guangzhou Baiyunshan Pharmaceutical Holdings Co SHSE:600332 +1.92% 67 Construction In Progress is ¥1,253 Mil as of Mar. 2026. GuruFocus rates SHSE:600332 with a GF Score™ of 67/100 and a GF Value™ of ¥29.39 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's quarterly construction in progress declined from Sep. 2025 (¥1,879 Mil) to Dec. 2025 (¥1,150 Mil) but then increased from Dec. 2025 (¥1,150 Mil) to Mar. 2026 (¥1,253 Mil).

Guangzhou Baiyunshan Pharmaceutical Holdings Co's annual construction in progress declined from Dec. 2023 (¥2,405 Mil) to Dec. 2024 (¥1,846 Mil) and declined from Dec. 2024 (¥1,846 Mil) to Dec. 2025 (¥1,150 Mil).

Guangzhou Baiyunshan Pharmaceutical Holdings Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Construction In Progress Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Construction In Progress

Get a 7-Day Free Trial

1,564.09

2,108.33

2,405.17

1,846.19

1,149.62

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Construction In Progress	Get a 7-Day Free Trial															1,928.95	1,846.00	1,878.97	1,149.62	1,253.11

67GF Score

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHSE:600332

Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Frequently Asked Questions Learn more about Construction In Progress →

What does a Construction In Progress of ¥1,253 Mil mean?

Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) has a Construction In Progress of ¥1,253 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Construction In Progress too high?

Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Construction In Progress is ¥1,253 Mil. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Construction In Progress compare to MCK and CAH?

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Construction In Progress of ¥1,253 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Construction In Progress for a Medical Distribution company?

A good Construction In Progress depends on the Medical Distribution industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Construction In Progress mean?

A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Construction In Progress is ¥1,253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.39, compared to a current price of ¥21.19 — trading 27.9% below its estimated fair value. The current Construction In Progress is ¥1,253 Mil. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Construction In Progress calculated?

Construction In Progress is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332), the current Construction In Progress is ¥1,253 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of ¥21.19 is trading 27.9% below its estimated GF Value™ of ¥29.39. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Modestly Undervalued.

Key valuation signals for SHSE:600332:

Construction In Progress: ¥1,253 Mil
GF Value™: ¥29.39 vs. price of ¥21.19 (27.9% below fair value)
GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Industry Healthcare Medical Distribution

Comparable Companies SHSE:600998 SHSE:600511 SHSE:600739 SHSE:600056 SZSE:000028 SZSE:301015 SHSE:601607 SZSE:000950 SZSE:301584 SHSE:603368 MCK CAH COR ASX:SIG HSIC HKSE:01099 XSWX:GALE TSE:7459 OSTO:ASKER MIL:AMP

Other Exchanges 00874:Hong Kong GU5:Germany

Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130

Website https://www.gybys.com.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.

67GF Score

Get the complete analysis for SHSE:600332

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.19

Price

¥29.39

GF Value

View SHSE:600332 Analysis

See Construction In Progress data for all stocks →